The Aethlon Hemopurifier® is a first-in-class technology designed for the rapid depletion of circulating viruses and cancer-promoting exosomes. The United States Food and Drug Administration (FDA) has designated the Hemopurifier® as a “Breakthrough Device” for the treatment of life- threatening viruses for which there are no approved therapies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.